All Posts:Ewing sarcoma
-
Georgetown Lombardi’s Jeffrey Toretsky, MD, Honored with Hyundai Hope on Wheels Endowed Chair in Pediatric Oncology
Hyundai Hope On Wheels, one of the largest nonprofit funders of pediatric cancer research in the country, has awarded its first Hyundai Hope on Wheels Endowed Chair for Pediatric Oncology to Jeffrey Toretsky, MD, at Georgetown’s Lombardi Comprehensive Cancer Center.
Category: Lombardi Stories
-
Biological Pathways Found That Drive Genomic Changes and Bone Metastasis in Ewing Sarcoma, a Rare Childhood Cancer
WASHINGTON (April 28, 2022) — In studies using mice grafted with human Ewing sarcoma tissue, researchers from Georgetown University Medical Center and colleagues have identified a biological pathway that is activated when tissue is starved of oxygen due to rapid growth of a tumor, thereby allowing cancer cells to make genetic changes so they can […]
Category: News Release
-
Toretsky Looks to ‘Outsmart Cancer Cells’ with Help From Hyundai Hope on Wheels Award
Childhood cancer survivors, Georgetown Lombardi oncologists and representatives from Hyundai Motor America all gathered on a sunny day outside of the Medical-Dental Building to celebrate Jeffrey Toretsky, MD, as the recipient of the 00,000 Hyundai Hope On Wheels award.
Category: Lombardi Stories
-
Unique Research Approach Finds FDA Approved Drug Shuts Down Ewing Sarcoma Cells in Lab
Based on a novel approach to drug discovery, researchers at Georgetown Lombardi Comprehensive Cancer Center say an agent approved to treat a type of leukemia might also help young people with a much rarer and aggressive form of cancer, Ewing sarcoma.
Category: News Release
-
Two Agents Deliver Knockout Punches to Ewing Sarcoma
When combined with an already FDA-approved chemotherapy, a novel agent developed by researchers at Georgetown University Medical Center appears to halt the ability of Ewing sarcoma to grow and progress.
Category: Lombardi Stories
-
Clinical Trial Underway to Test Innovative Cancer Treatment Based on Georgetown Discoveries
This August, the first patient in a multi-center clinical trial being conducted by Oncternal Therapeutics began receiving an innovative new investigational cancer therapy based on discoveries made by Toretsky, professor and leader of the molecular oncology program at the Georgetown Lombardi Comprehensive Cancer Center, and his colleagues.
Category: Lombardi Stories
-
Lombardi Scientist Receives Innovation Grant for Research on Pediatric Cancer
July 20, 2015 — There’s good news on the horizon for children battling a rare form of bone cancer. Dr. Todd Waldman, a professor of oncology at Georgetown Lombardi Comprehensive Cancer Center, has been awarded an Innovation Grant from Alex’s Lemonade Stand Foundation (ALSF) in support of his groundbreaking cancer research. At the center of […]
Category: Lombardi Stories
-
‘Friends of Colin’ Donates $20,000 Towards Ewing Sarcoma Research at Georgetown Lombardi
March 20, 2015 — People might be surprised to discover that a $20,000 donation to Georgetown Lombardi Comprehensive Cancer Center is the work of three teenagers. For the past four years, Friends of Colin, a nonprofit group formed by three Cranford, N.J. neighbors, Ryan McGann, Gary Hoffman and Maggie McKay, has been supporting Ewing sarcoma […]
Category: Lombardi Stories
-
Cancer Researcher Goes in New Direction with St. Baldrick’s Support
Jeffrey Toretsky, MD, a pediatric oncologist and researcher at Georgetown Lombardi, has received a $100,000 St. Baldrick’s Research Grant with generous support from the Team Clarkie Fund, a St. Baldrick’s Hero Fund.
Category: Lombardi Stories